DR. VIJAYA KORRAPATI M.D. NPI 1033186713

NPI Details

DR. Vijaya Korrapati, M.D. is a hematology and oncology internal medicine in West Columbia, SC with 34 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Vijaya Korrapati, M.D. NPI is 1033186713. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

222 E MEDICAL LN STE 400
WEST COLUMBIA, SC
ZIP 29169-848
Phone: (803) 794-7511
Fax: (803) 794-7751

The NPI 1033186713 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, bevacizumab, 10 mg (HCPCS:J9035)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg (HCPCS:Q5117)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Liver function blood test panel (HCPCS:80076)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Ferritin (blood protein) level (HCPCS:82728)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Magnesium level (HCPCS:83735)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Ct scan of chest with contrast (HCPCS:71260)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Adrenocorticotropic hormone (acth) level (HCPCS:82024)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood creatinine level (HCPCS:82565)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Automated urinalysis test (HCPCS:81003)
• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Ct scan of chest without contrast (HCPCS:71250)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 3/2/2006 and was last updated on 11/9/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.